http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110294709-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
filingDate 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110294709-B
titleOfInvention 1,3- [2H,4H ] -isoquinoline dione derivative and preparation method and application thereof
abstract The invention belongs to the field of biomedicine, and particularly relates to 1,3- [2H,4H ]]-isoquinolinedione derivatives, their preparation and use. The 1,3- [2H,4H]The structural general formula of the isoquinoline diketone derivative is shown as a general formula (1), wherein, R is H, F, Cl, Br, -CH 3 、‑OCH 3 One or two of methylthio, ethyl, amino and acetyl; r 1 The radicals being H, F, Cl, Br, -CH 3 、‑OCH 3 One or two of methylthio, ethyl, amino and acetyl; r 2 The radical being-CH 3 Ethyl, acetyl, benzyl, propenyl and phenyl. 1,3- [2H,4H ] of the invention]The-isoquinoline dione derivative has a good inhibition effect on an acinetobacter baumannii quorum sensing system, the harm of the acinetobacter baumannii is greatly reduced, the preparation method is simple, and the prepared product can be used as a biomembrane inhibitor to be applied to preparation of anti-infection chiral drugs.
priorityDate 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID349435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22673023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415800644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425985522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3472400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419777905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455784172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411294233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 42.